Big pharmaceutical firms agree to generic drugs for Rwanda
October 27, 2009 by Fred · Leave a Comment
AFP – Three pharmaceutical firms said Monday they support continued efforts by a Canadian generic drug maker to distribute cheaper versions of their patented HIV/AIDS medicines in Rwanda.
GlaxoSmithKline and the Canadian subsidiaries of Shire and Boehringer Ingelheim had two years ago authorized Canadian generic drug maker Apotex to export to Rwanda a “fixed dose triple combination antiretroviral medicine” containing drugs over which each held patent rights in Canada. Read more
